NCT06029374 Therapy of Fifth Metacarpal Neck Fractures - Comparing Functional Treatment With Reposition and Finger Splinting
| NCT ID | NCT06029374 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Boxer's Fracture |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-10-01 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this prospective randomized controlled clinical trial is to evaluate if functional treatment leads to a better functional outcome than a forearm cast and a finger splint in patients with fifth metacarpal neck fracture.
Eligibility Criteria
Inclusion Criteria: * Fifth Metacarpal Neck Fractures * Patient age between 18 and 70 years Exclusion Criteria: * Palmar angulation \>50° in first lateral x-ray * Pathologic fracture * Intraarticular fracture * Patients unable to consent * Polytraumatized patients * Pregnancy * Compound fractures * Multiple hand injuries * Patients initially presenting more than 7 days after injury
Contact & Investigator
Gerhild Thalhammer, M.D.
STUDY DIRECTOR
Medical University of Vienna
Frequently Asked Questions
Who can join the NCT06029374 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Boxer's Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06029374 currently recruiting?
Yes, NCT06029374 is actively recruiting participants. Contact the research team at paul.hoppe@meduniwien.ac.at for enrollment information.
Where is the NCT06029374 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT06029374 clinical trial?
NCT06029374 is sponsored by Medical University of Vienna. The principal investigator is Gerhild Thalhammer, M.D. at Medical University of Vienna. The trial plans to enroll 100 participants.